logo
You need more than Ozempic to fight food addiction. Here's how

You need more than Ozempic to fight food addiction. Here's how

Are cookies and chips the new cigarettes? And soda, breakfast cereals and ice cream the new opioids?
In his new book, 'Diet, Drugs, and Dopamine: The New Science of Achieving a Healthy Weight' (Flatiron Books), former FDA Commissioner David A. Kessler argues that ultraprocessed foods — meaning 'irresistible, highly processed, highly palatable, energy-dense, high-glycemic foods,' as he describes them — have been purposefully engineered by Big Food to be addictive. He calls them 'ultraformulated' instead of 'ultraprocessed' so as to highlight the deliberate intent on the part of food manufacturers. As a result, 41.9% of adults in the U.S. struggle with obesity, he says. And by 2030, he projects about half of us will.
It's a 'health catastrophe,' Kessler says, 'that has reached its apex on every level.'
Toxic or visceral fat — meaning fat around our internal organs — has led to a rise in diseases and conditions such as Type 2 diabetes, arthritis, blood clots, hypertension, cardiovascular disease, dementia, stroke and certain cancers.
GLP-1 weight loss drugs, such as Wegovy and Zepbound, have helped millions of people shed weight and curb food cravings. But they create additional health problems, Kessler says, and there's not enough scientific data accrued yet to speak to their efficacy or safety, long-term.
It's a topic Kessler is intimately familiar with. He's battled food addiction since childhood, growing up in New York, and his addiction ballooned in college and medical school when sub sandwiches and chicken wings were his rewards for studying hard. He's since struggled with managing the side effects of GLP-1 drugs. To reverse the obesity crisis, says Kessler, we need to better understand addiction itself: how ultraprocessed foods take hold of our rational brain. We must also create a new paradigm for addiction, Kessler says, as the current one views addicts through the lens of weakness.
In his book, Kessler urges us to recognize that obesity is a chronic condition that needs to be treated as such.
The Times spoke with Kessler about healthy weight loss strategies for the long-term, guidelines for using GLP-1s safely, the body positivity movement and improving lifespan.
This interview has been condensed and edited for clarity.
In the book, you talk about 'the elephant in the room' when it comes to struggles around weight loss today. What is it?
We've failed to recognize how difficult it is to escape the pull of food addiction and overcome our brain's built-in reward response to these ultraformulated foods that flood our food supply. I'm not talking about cocaine or amphetamines that excessively hijack the dopamine circuits. But the addictive circuits are part of all of us. We are all wired to focus on the most salient stimuli in our environment. And for many of us, that stimuli are these ultraformulated foods. Food is very, very powerful in changing how we feel. It's not a question of willpower. Our bodies have experienced an insidious decline over the past half a century. And that's been caused by this never-ending consumption of foods that can trigger the addictive circuits.
How can we 'quiet the noise,' as you say, around food addiction?
It's the interaction between the stimuli in our environment and our brains. Change our environment, and we can remarkably change what's going on in our brains. [Environment] is everything outside our bodies that we interact with, from the moment we wake up to the moment we go to sleep. What you put on your TV, what fast food restaurants you pass by on the way to work, we are constantly being cued. So you try to eliminate the cues. Or change your environment. Many of us don't have the opportunity to leave our environment. And the food industry isn't prone to change their behavior any time soon. But we now have pharmaceutical aids to help tamp that down. The effect of these GLP-1 [weight loss] drugs on food noise, that's the big discovery.
GLP-1 drugs can lead to serious medical conditions that concern you. What are they, and what should doctors and drug companies be doing differently?
The fact is that the only way you're going to lose weight — whether it's drugs or diet or surgery — is to have an energy deficit. [GLP-1s] are very effective at getting you to consume less. But some people are eating less than 1,000 calories a day. There are people eating 600, 800 calories. You have to be under medical care or you run the risk of malnutrition. Food stays in your gut longer and that delay in gastric entering [called gastroparesis] can cause its own set of symptoms as well as metabolic consequences such as hypoglycemia, low blood sugar and other metabolic states. They all result from malnutrition.
Many doctors who are prescribing this are not well-trained in obesity medicine or in nutrition. And it's very important, if possible, that a team of healthcare professionals, including a dietitian, be available. There's no doubt that [drug companies] need to do a better job of studying the real world data. How to use these drugs, how to safely get off these drugs, is a key issue. There needs to be better labeling surrounding gastroparesis and the risks associated with these drugs.
Most people aren't going to be on GLP-1s for life because they're expensive and have adverse effects, you say. Yet going off the drugs, most people gain back the weight. So what's the solution, long-term?
The question is about intermittent use — can I use these drugs to get my weight off? Then can I use them, intermittently, over a lifetime? But we don't have data yet to know [if] that's safe. But you can use these drugs to condition yourself to learn how to eat differently. I eat very differently now — I don't want to put large amounts of food in my stomach. I've conditioned myself not to do that. How long that will last, we'll see. So you need a range of tools. That can range from nutrition therapy to behavioral therapy to physical activity — and they're going to vary for the individual. There's no one tool that's gonna work for the duration. The pharmacological tools are only one tool, it's the entire tool box that has to be available. But the most important thing is to recognize that this is a chronic condition that needs continuous care, even after you've lost the weight.
Achieving a healthy body weight starts with understanding addiction, you say, not necessarily the old advice to 'eat less and move more.' Why is this so important?
The ultimate answer is 'eat less and move more.' But we can't do that because of the physiological and addictive circuits — they stand in the way. We have to understand that addiction is not just about the weak and the downtrodden. It's part of all of us, those circuits. We can't overestimate the amount of stigma and shame and distress that many feel because they've been unable to control their weight. They feel it's their fault, they don't like themselves for it and society has created all these biases attached to it. The simple recognition [that] our brains are not fully under our control when it comes to these energy dense foods is a very important step.
There's a delicate balance between the body positivity movement, which encourages people to accept their bodies as they are, and the health crisis that is obesity, which you say is a root cause of many diseases. How do you suggest we navigate that?
That movement did a lot of good — it took the shame out of it, it took the stigma out. But it was at a time when we didn't have effective tools to reduce visceral fat. You can love your body, but also do things for your health. Those things are not diametrically opposite. And I'm not comfortable with the amount of morbidity and mortality associated with visceral fat and saying we shouldn't do something about that.
As former commissioner of the FDA, what keeps you up at night these days?
The recognition that visceral fat is causal in an array of cardiometabolic diseases that increase real disability in one's senior years. I think we're not prepared to handle that. We've only woken up to the fact of how toxic this visceral fat is.
[Also], Trump's greatest achievement, in the first term, was Operation Warp Speed. And I was part of it beginning January 2021. The reason we were able to do what we did, and get those vaccines safely developed and produced and distributed, was because there existed institutions within our federal government: the [National Institutes of Health], the [U.S. Food and Drug Administration], the [Center for the Biomedical Advanced Research and Development Authority], the [Centers for Disease Control and Prevention]. Those institutions had enormous expertise and resources. And yes, we had to put it together; yes, we had to do things differently. But we were able to build on that infrastructure. Now they're destroying that infrastructure. I don't get it.
To end on a positive note: What amount of weight loss actually decreases future risk of disease?
What's remarkable is that relatively small amounts can have significant effects. If you want to reverse certain conditions, that would require more weight loss. But almost any weight loss is going to add clinical benefits and be useful in reducing cardiometabolic risk.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RFK Jr. will ‘end the war' against alternative medicine at the FDA, from stem cell therapy to chelation. Here's what to know
RFK Jr. will ‘end the war' against alternative medicine at the FDA, from stem cell therapy to chelation. Here's what to know

Yahoo

time36 minutes ago

  • Yahoo

RFK Jr. will ‘end the war' against alternative medicine at the FDA, from stem cell therapy to chelation. Here's what to know

Health and Human Services Secretary Robert F. Kennedy, Jr. doubled down on his support for non-pharmaceutical health treatments during a recent podcast appearance, saying, 'We're going to end the war at the FDA against alternative medicine.' Speaking on the Ultimate Human podcast with host Gary Brecka, a 'renowned Human Biologist, biohacker, and longevity expert,' according to the website, Kennedy said he would fix the U.S. Food and Drug Administration's bias against the following: stem cell treatments, chelating drugs, vitamins and minerals, amino acids, peptides, and hyperbaric chambers. 'Our position is that the FDA has a job: Just do the science on these kinds of issues and then tell the public what they've learned from the science … but don't tell physicians what they can and cannot prescribe,' he said. And as far as the patients go, he said, 'If you want to take an experimental drug … you ought to be able to do that.' RFK Jr. added, 'We don't want to have the Wild West. We want to make sure that information is out there. But we also want to respect the intelligence of the American people' to decide what treatments will benefit them the most. He acknowledged that, with this approach, there will be 'charlatans' as well as 'people who have bad results' from various alternative treatments. 'But ultimately,' he said, 'you can't prevent that either way, and leaving the whole thing in the hands of pharma is not working for us.' Brecka called Kennedy's pronouncements 'music to my ears.' Below, what you need to know about the alternative therapies RFK Jr. is advocating for. What is it: It's a way to repair diseased or injured tissue in the body using stem cells—cells that can self-renew or become other types of tissues—typically grown in a lab, manipulated, and then be implanted into the patient. What it does: Though it's considered to be largely experimental, the FDA does permit stem cell therapies for blood and immune disorders. Leukemia, lymphoma, neuroblastoma, and multiple myeloma, for example, are also often treated this way, with bone marrow treatments, which are backed by decades of science. Other types of the treatment are still in clinical trials, while more and more wellness centers are offering the treatment for unapproved reasons, using cells drawn from the patient's body and injected back in without manipulation for everything from autism and ALS to Parkinson's and better skin, according to the New York Times. Kennedy told Brecka that he received the treatment for his voice disorder, spasmodic dysphonia, and that it helped him 'enormously,' but that he had to go to Antigua to access it. Risks: For starters, wellness clinic treatments cannot guarantee they are using actual stem cell, reported the Times. And improper injections can lead to a host of terrible consequences—clots, infections, blindness, and even the formation of tumors, which the FDA warned of in 2021. What it is: Chelation involves the use of certain chemicals to remove toxic heavy metals, such as mercury and lead, from the body; all FDA-approved chelation therapy products require a prescription and can only be used safely under the supervision of a healthcare practitioner. What it does: Some alternative medicine practitioners offer chelation therapy, through pill or injection, as a way to treat Alzheimer's, autism, diabetes, high blood pressure, or Parkinson's disease, all of which are unapproved and risky. Children's Health Defense, founded by Kennedy, has written about chelation as a way to treat autism, which compares 'autism with mercury poisoning' due to childhood vaccines that contained the preservative thimerosal (largely mercury) before it was removed in 2001. Some flu shots still contain the preservative, but, says the Centers for Disease Control and Prevention, 'There is no evidence of harm caused by the low doses of thimerosal in vaccines.' Risks: The FDA warns specifically about using chelation therapy for autism, and notes, 'Chelating important minerals needed by the body can lead to serious and life-threatening outcomes.' While minor risks may include fever, headache, muscle pain, and nausea or vomiting, severe reactions range from heart failure and kidney damage to respiratory failure and seizures, according to the Cleveland Clinic. What they are: Dietary supplements in almost every letter of the alphabet, from A to zinc, are over-the-counter pills or liquids that contain nutritional boosts of vitamins and minerals. What they aim to help: Vitamin and mineral supplements aim to fill in with necessary nutrients that a person is not getting through food—though nutritionists believe that healthy food is the best source of such vitamins and minerals. Studies have found supplements may help with practically any issue under the sun—energy, heart issues, cognitive function, gut health, sleep, and more. Risks: The U.S. Food and Drug Administration regulates supplements, but doesn't approve them for safety or effectiveness before they are sold to the public. Some may cause liver damage and toxicity, while others may just be a waste of money. What it is: Amino acids are often referred to as the 'building blocks of proteins,' needed for building proteins, hormones, and neurotransmitters. are compounds that play many critical roles in your body. You need them for vital processes such as building proteins, hormones, and neurotransmitters. Amino acids are concentrated in protein-rich foods such as meat, fish, and soybeans, and foods that contain all nine essential amino acids are called complete proteins. Peptides are short proteins, and come in the form of hormones such as follicle-stimulating hormone (FSH), and creatine and collagen. What they aim to help: Amino acid supplements may help with various issues—such as L-arginine for blood flow and inflammation; tryptophan for mood and sleep; and valine, leucine, and isoleucine to help with energy and athletic performance. Taking collagen supplements may help strengthen nails and bones, while people take creatine for boosting workouts and building muscle growth. Risks: Side effects of taking either can range from toxicity and gastrointestinal issues to effects on brain function muscle protein balance. Creatine may cause muscle cramps and digestive problems (and may not have many benefits), while tryptophan may cause dizziness, headache, or nausea. And again, as with all supplements, the U.S. Food and Drug Administration regulates them, but doesn't approve them for safety or effectiveness before they are sold to the public. What it is: Hyperbaric oxygen therapy in a medical-grade, FDA-approved chamber lets you breathe pure oxygen—as opposed to everyday air, which is just 21% oxygen mixed with nitrogen. Hyperbaric oxygen is also highly pressurized, thereby allowing the lungs to take more in. Home chambers (used by folks including Lebron James, LeAnn Rimes, and Mayim Bialik), as well as those offered in many wellness clinics, do not deliver 100% oxygen. Instead, they use regular air that is 30% more pressurized than normal for what's known as 'mild hyperbarics.' What it aims to help: The FDA has been regulating HBOT chambers since 1976, and has officially cleared 13 medical conditions—such as decompression sickness, burns, radiation injury, and certain wounds—for such treatment. But it's used off-label for many other reasons, including concussions, traumatic brain injury, long COVID, age reversal, stroke recovery, fibromyalgia, and improved brain function, many of which are being looked at in ongoing clinical trials. Risks: For medical-grade chambers, risks include ear and sinus pain, middle ear injuries, temporary vision changes, and lung collapse, which is rare, according to the FDA. For mild hyperbarics, risks include potential exposure to toxic oils from some compressors, carbon dioxide buildup that brings a risk of hypoxia inside the chamber—or, according to some experts and a body of inconclusive evidence, that the treatment may simply be ineffective. This story was originally featured on

Revelation-Backed Omada Health Jumps After $150 Million IPO
Revelation-Backed Omada Health Jumps After $150 Million IPO

Yahoo

timean hour ago

  • Yahoo

Revelation-Backed Omada Health Jumps After $150 Million IPO

(Bloomberg) -- Omada Health Inc. shares ended their debut trading day exactly where they started after the digital health-care company raised $150 million in its initial public offering. Next Stop: Rancho Cucamonga! ICE Moves to DNA-Test Families Targeted for Deportation with New Contract Where Public Transit Systems Are Bouncing Back Around the World US Housing Agency Vulnerable to Fraud After DOGE Cuts, Documents Warn Trump Said He Fired the National Portrait Gallery Director. She's Still There. The stock climbed 21% to close at $23 on Friday in New York — the same price it opened at — higher than its IPO price of $19 per share. The stock had jumped as much as 49% during the the trading session. The San Francisco-based company sold 7.9 million shares at $19 each after offering them at $18 to $20 apiece, according to its filings with the US Securities and Exchange Commission. The trading gives Omada a market value of $1.3 billion based on the number of outstanding shares listed in its filings. The IPO adds to the growing pace of US first-time share sales this year, which have raised around $24.9 billion so far, versus $17.6 billion in the same period last year, according to data compiled by Bloomberg. Shares of health-care upstarts that went public on US exchanges this year are also up by a weighted average of roughly 18%, according to Bloomberg calculations. An IPO last month for digital physical therapy provider Hinge Health Inc. — a competitor to Omada — raised $503 million, and shares have risen about 19% since its debut. Omada's offering closed with orders for more than 15 times the shares available, with allocations going to a highly concentrated group of investors, Bloomberg News has reported. Virtual Care Founded in 2011, Omada provides virtual care in between doctor's visits to help people manage chronic conditions including diabetes and prediabetes, obesity, hypertension and musculoskeletal conditions, according to the filing. Users track metrics including weight, blood pressure and blood glucose values to the company's platform, which includes a mobile app. Unlike other digital health firms, Omada doesn't offer GLP-1 weight loss drugs, the filing shows. Instead it has programs to support people using them, including coaching and nutrition guidance, to manage muscle loss and stop the weight from returning when they cease taking the medication, according to the filing. About 50,000 of Omada's 679,000 members are on GLP-1s, co-founder and Chief Executive Officer Sean Duffy said in an interview with Bloomberg News. It's a relatively new business for the company that has expanded in the past year as part of its partnership with Cigna Group's Express Scripts unit, he said. 'For support, especially in chronic disease, it's very helpful that someone feels they are not just doing this for themselves but for someone else - to have someone rooting for you in your corner is really important for outcomes,' Duffy said. Omada is using AI to automate the virtual care it provides to chronic disease sufferers, though the services are 'human-led,' he said. 'Our members tell us they want a person and I am yet to see anyone that feels accountable to ChatGPT,' Duffy said. Omada has over 2,000 customers including employers and health systems, and more than 679,000 total members enrolled in one or more programs, according to the filing. Largest Shareholder Revelation Partners is Omada's largest shareholder, beneficially owning 10.9% of the company before the offering, according to the filing. USVP has 9.9% of the shares, Andreessen Horowitz has 9.6% and FMR has 9.3%, the filing shows. Omada was valued at more than $1 billion in a 2022 funding round led by Fidelity Management & Research Co., it said in a statement at the time. The company had a net loss of $9.4 million on revenue of close to $55 million in the first three months of 2025, compared with a net loss of nearly $19 million on revenue of $35.1 million in the same period a year earlier, the filing shows. The offering was led by Morgan Stanley, Goldman Sachs Group Inc. and JPMorgan Chase & Co., the filing shows. The company's shares trade on the Nasdaq Global Market under the symbol OMDA. (Updates with closing prices.) Cavs Owner Dan Gilbert Wants to Donate His Billions—and Walk Again The SEC Pinned Its Hack on a Few Hapless Day Traders. The Full Story Is Far More Troubling YouTube Is Swallowing TV Whole, and It's Coming for the Sitcom Is Elon Musk's Political Capital Spent? Trump Considers Deporting Migrants to Rwanda After the UK Decides Not To ©2025 Bloomberg L.P.

Popular Aldi snack recalled due to potential ‘life-threatening' allergen
Popular Aldi snack recalled due to potential ‘life-threatening' allergen

Yahoo

timean hour ago

  • Yahoo

Popular Aldi snack recalled due to potential ‘life-threatening' allergen

Aldi is recalling one of its sweet treats due to the presence of an undeclared allergen. The U.S. Food and Drug Administration (FDA) issued a notice on Tuesday to announce that Camerican International was recalling 7.05 oz boxes of Casa Mamita Churro Bites Filled with Chocolate Hazelnut Cream. The recall was issued because the Aldi brand snack may contain undeclared milk, so consumers with an allergy or 'severe sensitivity to milk run the risk of serious or life-threatening allergic reaction,' per the FDA. The recalled churro bites were distributed at Aldi stores in 13 states: Alabama, Arkansas, Florida, Georgia, Iowa, Illinois, Kentucky, Louisiana, Missouri, Mississippi, North Carolina, South Carolina, and Tennessee. The 7.05 oz cardboard boxes are marked with a 'Best If Used By' date of July 14, 2025, and the Lot Number '01425.' According to the FDA, the recall was initiated after a 'consumer discovered that the milk-containing product was distributed in packaging that did not reveal the presence of milk.' A subsequent investigation revealed the mistake was a result of a 'temporary breakdown in the company's production and packaging processes,' which has since been corrected. However, there have been no illnesses reported to date due to this product. Consumers are now urged to return the churro bites to the place of purchase for a full refund. This isn't the first time Aldi food item to be recalled recently. In May, Santa Monica Seafood of Rancho Dominguez, California, issued a voluntary recall on its Atlantic Salmon Portions with Seafood Stuffing because they may have contained undeclared soy. The affected salmon portions were sold in three states: California, Nevada, and Arizona. The products were sold in 16-ounce packages and had a use/freeze-by date of June 2, 2025. The last two years have also seen an alarming and unexplained rise in recalls. In 2024, approximately 300 food recalls were issued, with those recalls being linked to nearly 1,400 illnesses, a Public Interest Research Group report revealed. Out of the 1,400 illnesses, 487 people became sick enough to require hospitalization, and 19 people died. While those numbers are still low when weighed against the entire U.S. population, they are also double the number of hospitalizations and deaths from food-borne illnesses in 2023. Earlier in May, cucumbers sold across the country were recalled after people in 15 states reported getting ill from salmonella. Florida-based Bedner Growers, Inc. recalled the vegetables distributed by Fresh Start Produce Sales, Inc. from April 29 to May 19.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store